Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Current Challenges in the Development of Therapeutic Peptides.

Created on 13 Nov 2026

Authors

Hui Tyng Lee, Keat Lam Ho, Phelim Voon Chen Yong, Sau Har Lee

Published in

Current protein & peptide science. Nov 11, 2026. Epub Nov 11, 2026.

Abstract

Therapeutic peptides have emerged as an increasingly important class of therapeutics, offering high target specificity, potent biological activity, and considerable potential for the treatment of diverse diseases. Despite these advantages, their successful development and clinical translation remain constrained by interconnected scientific, clinical, technological, and regulatory challenges. Key scientific and technological barriers include achieving adequate target and receptor specificity, maintaining peptide stability against enzymatic and physiological degradation, overcoming biological barriers, and developing effective delivery strategies with improved bioavailability and control of targeted release. Clinical translation is further complicated by inter-patient variability, lack of biomarkers and pharmacogenomic data, immune-related responses, incomplete long-term safety and efficacy data, and the emergence of therapeutic resistance. In addition, manufacturing complexity, commercial considerations, and regulatory requirements can further impede the progression of promising peptide candidates toward clinical application. This review provides an integrated examination of these challenges across the therapeutic peptide development pipeline, highlighting their interrelationships and their implications for efficacy, safety, patient selection, and clinical translation. Particular emphasis is placed on emerging strategies in peptide engineering, formulation and delivery advancements, biomarker-guided and personalized approaches, and regulatory harmonization that may help overcome current barriers. By integrating scientific and translational perspectives, this review identifies key areas requiring continued innovation and coordinated efforts to facilitate the development, clinical adoption, and broader accessibility of therapeutic peptides.

PMID:
43023438
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement